ImmuCell Corporation Capital Expenditures
ImmuCell Corporation (ICCC) reported Capital Expenditures of $911.17 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-13
- ImmuCell Corporation payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $733.94K, a 373.02% increase year-over-year.
- ImmuCell Corporation payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $177.23K, a 46.14% decline year-over-year.
- ImmuCell Corporation payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $172.31K, a 12.19% decline year-over-year.
- ImmuCell Corporation payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $593.92K, a 571.77% increase year-over-year.
- ImmuCell Corporation payments to acquire property, plant, and equipment for fiscal 2025 was $1.25M, a 168.49% increase from fiscal 2024.
- ImmuCell Corporation payments to acquire property, plant, and equipment for fiscal 2024 was $465.73K, a 75.39% decline from fiscal 2023.
- ImmuCell Corporation payments to acquire property, plant, and equipment for fiscal 2023 was $1.89M, a 52.39% decline from fiscal 2022.
- ImmuCell Corporation payments to acquire property, plant, and equipment for fiscal 2022 was $3.98M, a 52.39% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $733.94K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $911.17K 10-Q · filed 2026-08-13 | $1.08M derived: sum of 3 quarters · filed 2026-08-13 | $1.68M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $177.23K 10-Q · filed 2026-05-14 | $349.54K derived: sum of 2 quarters · filed 2026-05-14 | $943.46K derived: sum of 3 quarters · filed 2026-05-14 | $1.10M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $172.31K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $766.23K derived: sum of 2 quarters · filed 2026-03-30 | $921.39K derived: sum of 3 quarters · filed 2026-08-13 | $1.25M 10-K · filed 2026-03-30 |
| 2025-09-30 | $593.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $749.08K derived: sum of 2 quarters · filed 2026-08-13 | $1.08M 10-Q · filed 2025-11-13 | $1.27M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $155.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $484.21K 10-Q · filed 2026-08-13 | $680.42K derived: sum of 3 quarters · filed 2026-08-13 | $768.84K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $329.05K 10-Q · filed 2026-05-14 | $525.27K derived: sum of 2 quarters · filed 2026-05-14 | $613.68K derived: sum of 3 quarters · filed 2026-05-14 | $724.42K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $196.22K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $284.63K derived: sum of 2 quarters · filed 2026-03-30 | $395.37K derived: sum of 3 quarters · filed 2026-03-30 | $465.73K 10-K · filed 2026-03-30 |
| 2024-09-30 | $88.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $199.15K derived: sum of 2 quarters · filed 2025-11-13 | $269.51K 10-Q · filed 2025-11-13 | $350.85K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $110.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $181.10K 10-Q · filed 2025-08-14 | $262.44K derived: sum of 3 quarters · filed 2025-08-14 | $682.96K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $70.36K 10-Q · filed 2025-05-14 | $151.70K derived: sum of 2 quarters · filed 2025-05-14 | $572.22K derived: sum of 3 quarters · filed 2025-05-14 | $1.28M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $81.34K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $501.86K derived: sum of 2 quarters · filed 2025-03-28 | $1.21M derived: sum of 3 quarters · filed 2025-03-28 | $1.89M 10-K · filed 2025-03-28 |
| 2023-09-30 | $420.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $1.13M derived: sum of 2 quarters · filed 2024-11-13 | $1.81M 10-Q · filed 2024-11-13 | $3.30M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $708.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $1.39M 10-Q · filed 2024-08-13 | $2.88M derived: sum of 3 quarters · filed 2024-08-13 | $3.62M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $682.17K 10-Q · filed 2024-05-14 | $2.17M derived: sum of 2 quarters · filed 2024-05-14 | $2.91M derived: sum of 3 quarters · filed 2024-05-14 | $3.85M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $1.49M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $2.22M derived: sum of 2 quarters · filed 2024-04-01 | $3.17M derived: sum of 3 quarters · filed 2024-04-01 | $3.98M 10-K · filed 2024-04-01 |
| 2022-09-30 | $734.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $1.68M derived: sum of 2 quarters · filed 2023-11-13 | $2.49M 10-Q · filed 2023-11-13 | $3.19M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $943.29K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $1.75M 10-Q · filed 2023-08-10 | $2.46M derived: sum of 3 quarters · filed 2023-08-10 | $3.13M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $807.50K 10-Q · filed 2023-05-11 | $1.51M derived: sum of 2 quarters · filed 2023-05-11 | $2.19M derived: sum of 3 quarters · filed 2023-05-11 | $3.07M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $704.59K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $1.38M derived: sum of 2 quarters · filed 2023-03-29 | $2.26M derived: sum of 3 quarters · filed 2023-03-29 | $2.61M 10-K · filed 2023-03-29 |
| 2021-09-30 | $675.40K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2022-11-21 | $1.55M derived: sum of 2 quarters · filed 2022-11-21 | $1.90M 10-Q · filed 2022-11-21 | $2.19M derived: sum of 4 quarters · filed 2022-11-21 |
| 2021-06-30 | $879.34K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2022-11-21 | $1.23M 10-Q/A · filed 2022-11-21 | $1.51M derived: sum of 3 quarters · filed 2022-11-21 | $2.99M derived: sum of 4 quarters · filed 2022-11-21 |
| 2021-03-31 | $349.32K 10-Q/A · filed 2022-11-21 | $634.00K derived: sum of 2 quarters · filed 2022-11-21 | $2.11M derived: sum of 3 quarters · filed 2022-11-21 | $3.17M derived: sum of 4 quarters · filed 2022-11-21 |
| 2020-12-31 | $284.68K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $1.76M derived: sum of 2 quarters · filed 2022-03-30 | $2.82M derived: sum of 3 quarters · filed 2022-03-30 | $4.07M 10-K · filed 2022-03-30 |
| 2020-09-30 | $1.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $2.54M derived: sum of 2 quarters · filed 2021-11-15 | $3.79M 10-Q · filed 2021-11-15 | $4.48M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $1.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $2.31M 10-Q · filed 2021-08-12 | $3.01M derived: sum of 3 quarters · filed 2021-08-12 | $3.41M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $1.25M 10-Q · filed 2021-05-13 | $1.94M derived: sum of 2 quarters · filed 2021-05-13 | $2.34M derived: sum of 3 quarters · filed 2021-05-13 | $2.45M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $691.43K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $1.09M derived: sum of 2 quarters · filed 2021-03-30 | $1.20M derived: sum of 3 quarters · filed 2021-03-30 | $1.39M 10-K · filed 2021-03-30 |
| 2019-09-30 | $399.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $505.61K derived: sum of 2 quarters · filed 2020-11-12 | $700.02K 10-Q · filed 2020-11-12 | $798.77K derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $105.73K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $300.14K 10-Q · filed 2020-08-12 | $398.88K derived: sum of 3 quarters · filed 2020-08-12 | $614.85K derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | $194.40K 10-Q · filed 2020-05-13 | $293.15K derived: sum of 2 quarters · filed 2020-05-13 | $509.12K derived: sum of 3 quarters · filed 2020-05-13 | $1.01M derived: sum of 4 quarters · filed 2020-05-13 |
| 2018-12-31 | $98.75K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $314.71K derived: sum of 2 quarters · filed 2020-03-27 | $816.64K derived: sum of 3 quarters · filed 2020-03-27 | $2.03M 10-K · filed 2020-03-27 |
| 2018-09-30 | $215.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $717.89K derived: sum of 2 quarters · filed 2019-11-12 | $1.93M 10-Q · filed 2019-11-12 | $6.61M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $501.93K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $1.72M 10-Q · filed 2019-08-12 | $6.40M derived: sum of 3 quarters · filed 2019-08-12 | $10.86M derived: sum of 4 quarters · filed 2019-08-12 |
| 2018-03-31 | $1.21M 10-Q · filed 2019-05-13 | $5.89M derived: sum of 2 quarters · filed 2019-05-13 | $10.36M derived: sum of 3 quarters · filed 2019-05-13 | $14.04M derived: sum of 4 quarters · filed 2019-05-13 |
| 2017-12-31 | $4.68M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $9.14M derived: sum of 2 quarters · filed 2019-03-22 | $12.83M derived: sum of 3 quarters · filed 2019-03-22 | $17.76M 10-K · filed 2019-03-22 |
| 2017-09-30 | $4.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $8.15M derived: sum of 2 quarters · filed 2018-11-13 | $13.08M 10-Q · filed 2018-11-13 | $14.87M derived: sum of 4 quarters · filed 2018-11-13 |
| 2017-06-30 | $3.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $8.62M 10-Q · filed 2018-08-13 | $10.41M derived: sum of 3 quarters · filed 2018-08-13 | $11.51M derived: sum of 4 quarters · filed 2018-08-13 |
| 2017-03-31 | $4.93M 10-Q · filed 2018-05-14 | $6.72M derived: sum of 2 quarters · filed 2018-05-14 | $7.83M derived: sum of 3 quarters · filed 2018-05-14 | $8.21M derived: sum of 4 quarters · filed 2018-05-14 |
| 2016-12-31 | $1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $2.90M derived: sum of 2 quarters · filed 2018-03-29 | $3.27M derived: sum of 3 quarters · filed 2018-03-29 | $3.59M 10-K · filed 2018-03-29 |
| 2016-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $1.48M derived: sum of 2 quarters · filed 2017-11-13 | $1.79M 10-Q · filed 2017-11-13 | $2.74M derived: sum of 4 quarters · filed 2017-11-13 |
| 2016-06-30 | $379.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $691.28K 10-Q · filed 2017-08-14 | $1.64M derived: sum of 3 quarters · filed 2017-08-14 | $1.98M derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-03-31 | $311.48K 10-Q · filed 2017-05-11 | $1.26M derived: sum of 2 quarters · filed 2017-05-11 | $1.60M derived: sum of 3 quarters · filed 2017-05-11 | $2.04M derived: sum of 4 quarters · filed 2017-05-11 |
| 2015-12-31 | $947.10K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | $1.28M derived: sum of 2 quarters · filed 2017-03-30 | $1.73M derived: sum of 3 quarters · filed 2017-03-30 | $2.72M 10-K · filed 2017-03-30 |
| 2015-09-30 | $337.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $783.63K derived: sum of 2 quarters · filed 2016-11-10 | $1.77M 10-Q · filed 2016-11-10 | $2.79M derived: sum of 4 quarters · filed 2016-11-10 |
| 2015-06-30 | $445.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $1.43M 10-Q · filed 2016-08-11 | $2.45M derived: sum of 3 quarters · filed 2016-08-11 | $2.66M derived: sum of 4 quarters · filed 2016-08-11 |
| 2015-03-31 | $988.46K 10-Q · filed 2016-05-11 | $2.00M derived: sum of 2 quarters · filed 2016-05-11 | $2.21M derived: sum of 3 quarters · filed 2016-05-11 | $2.48M derived: sum of 4 quarters · filed 2016-05-11 |
| 2014-12-31 | $1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | $1.22M derived: sum of 2 quarters · filed 2016-03-25 | $1.49M derived: sum of 3 quarters · filed 2016-03-25 | $1.54M 10-K · filed 2016-03-25 |
| 2014-09-30 | $207.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $475.29K derived: sum of 2 quarters · filed 2015-11-12 | $520.14K 10-Q · filed 2015-11-12 | $997.70K derived: sum of 4 quarters · filed 2016-03-25 |
| 2014-06-30 | $267.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $312.66K 10-Q · filed 2015-08-13 | $790.22K derived: sum of 3 quarters · filed 2016-03-25 | $826.94K derived: sum of 4 quarters · filed 2016-03-25 |
| 2014-03-31 | $44.85K 10-Q · filed 2015-05-12 | $522.41K derived: sum of 2 quarters · filed 2016-03-25 | $559.14K derived: sum of 3 quarters · filed 2016-03-25 | $633.60K derived: sum of 4 quarters · filed 2016-03-25 |
| 2013-12-31 | $477.56K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | $514.29K derived: sum of 2 quarters · filed 2016-03-25 | $588.75K derived: sum of 3 quarters · filed 2016-03-25 | $597.70K 10-K · filed 2016-03-25 |
| 2013-09-30 | $36.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $111.19K derived: sum of 2 quarters · filed 2014-11-12 | $120.14K 10-Q · filed 2014-11-12 | $145.96K derived: sum of 4 quarters · filed 2015-03-26 |
| 2013-06-30 | $74.46K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13 | $83.41K 10-Q · filed 2014-08-13 | $109.23K derived: sum of 3 quarters · filed 2015-03-26 | $121.85K derived: sum of 4 quarters · filed 2015-03-26 |
| 2013-03-31 | $8.95K 10-Q · filed 2014-05-14 | $34.77K derived: sum of 2 quarters · filed 2015-03-26 | $47.39K derived: sum of 3 quarters · filed 2015-03-26 | $171.88K derived: sum of 4 quarters · filed 2015-03-26 |
| 2012-12-31 | $25.82K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | $38.44K derived: sum of 2 quarters · filed 2015-03-26 | $162.93K derived: sum of 3 quarters · filed 2015-03-26 | $275.39K 10-K · filed 2015-03-26 |
| 2012-09-30 | $12.62K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $137.11K derived: sum of 2 quarters · filed 2013-11-13 | $249.57K 10-Q · filed 2013-11-13 | $305.37K derived: sum of 4 quarters · filed 2014-03-26 |
| 2012-06-30 | $124.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | $236.95K 10-Q · filed 2013-08-13 | $292.75K derived: sum of 3 quarters · filed 2014-03-26 | $328.14K derived: sum of 4 quarters · filed 2014-03-26 |
| 2012-03-31 | $112.46K 10-Q · filed 2013-05-14 | $168.26K derived: sum of 2 quarters · filed 2014-03-26 | $203.65K derived: sum of 3 quarters · filed 2014-03-26 | $225.83K derived: sum of 4 quarters · filed 2014-03-26 |
| 2011-12-31 | $55.80K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | $91.19K derived: sum of 2 quarters · filed 2014-03-26 | $113.37K derived: sum of 3 quarters · filed 2014-03-26 | $243.74K 10-K · filed 2014-03-26 |
| 2011-09-30 | $35.39K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-13 | $57.57K derived: sum of 2 quarters · filed 2012-11-13 | $187.93K 10-Q · filed 2012-11-13 | $194.31K derived: sum of 4 quarters · filed 2013-03-28 |
| 2011-06-30 | $22.18K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-07 | $152.54K 10-Q/A · filed 2012-09-07 | $158.92K derived: sum of 3 quarters · filed 2013-03-28 | $174.92K derived: sum of 4 quarters · filed 2013-03-28 |
| 2011-03-31 | $130.36K 10-Q · filed 2012-05-14 | $136.74K derived: sum of 2 quarters · filed 2013-03-28 | $152.74K derived: sum of 3 quarters · filed 2013-03-28 | |
| 2010-12-31 | $6.38K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $22.37K derived: sum of 2 quarters · filed 2013-03-28 | $116.55K 10-K · filed 2013-03-28 | |
| 2010-09-30 | $15.99K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $110.17K 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $94.17K 10-Q · filed 2011-08-15 | |||
| 2009-12-31 | $459.55K 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |